Thimerosal allergy and clinical relevance in Thailand

Journal of the Medical Association of Thailand

Volumn 90, Issue 9, 2007, Pages 1775-1779

  Wattanakrai, Penpun ^a   Rajatanavin, Natta ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Allergic contact dermatitis; Merthiolate; Patch test; Thimerosal

Indexed keywords

ALLERGEN; ANTIINFECTIVE AGENT; PIROXICAM; THIOMERSAL;

ADOLESCENT; ADULT; ALLERGY TEST; ARTICLE; CHILD; CONTACT DERMATITIS; CONTACT SENSITIZATION; CROSS REACTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATCH TEST; PREVALENCE; RISK FACTOR; SKIN ALLERGY; THAILAND; VACCINATION;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS, LOCAL; CHILD; CHILD, PRESCHOOL; DERMATITIS, ALLERGIC CONTACT; FEMALE; HUMANS; MALE; MIDDLE AGED; PATCH TESTS; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; THAILAND; THIMEROSAL; TIME FACTORS;

EID: 35848956330     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. th ed. Philadelphia: Lippincott Williams & Wilkins; 2001: 149-65.
2. Suneja T, Belsito DV. Thimerosal in the detection of clinically relevant allergic contact reactions. J Am Acad Dermatol 2001; 45: 23-7.
3. Tanglertsampan C, Sivasinangkura M. Boontanorm A, Ngamsiripol P. Allergic contact dermatitis to thimerosal: a case report. Thai J Dermatol 1998; 14: 57-62.
4. Ball LK, Ball R, Pratt RD. An assessment of thimerosal use in childhood vaccines. Pediatrics 2001; 107: 1147-54.
5. Belsito DV. Thimerosal: contact (non)allergen of the year. Am J Contact Dermat 2002; 13: 1-2.
6. Serrano G, Bonillo J, Aliaga A, Cuadra J, Pujol C, Pelufo C, et al. Piroxicam-induced photosensitivity and contact sensitivity to thiosalicylic acid. J Am Acad Dermatol 1990; 23: 479-83.
7. Wohrl S, Hemmer W, Focke M, Gotz M, Jarisch R. Patch testing in children, adults, and the elderly: influence of age and sex on sensitization patterns. Pediatr Dermatol 2003; 20: 119-23.
8. Marks JG Jr, Belsito DV, DeLeo VA, Fowler JF Jr, Fransway AF, Maibach HI, et al. North American Contact Dermatitis Group patch-test results, 1996-1998. Arch Dermatol 2000; 136: 272-3.
9. Hirano S, Yoshikawa K. Patch testing with European and American standard allergens in Japanese patients. Contact Dermatitis 1982; 8: 48-50.
10. Audicana MT, Munoz D, del Pozo MD, Fernandez E, Gastaminza G, Fernandez DC. Allergic contact dermatitis from mercury antiseptics and derivatives: study protocol of tolerance to intramuscular injections of thimerosal. Am J Contact Dermat 2002; 13: 3-9.
11. Schafer T, Bohler E, Ruhdorfer S, Weigl L, Wessner D, Filipiak B, et al. Epidemiology of contact allergy in adults. Allergy 2001; 56: 1192-6.
12. Freiman A, Al Layali A, Sasseville D. Patch testing with thimerosal in a Canadian center: an 11-year experience. Am J Contact Dermat 2003; 14: 138-43.
13. Perrenoud D, Bircher A, Hunziker T, Suter H, Bruckner-Tuderman L, Stager J, et al. Frequency of sensitization to 13 common preservatives in Switzerland. Swiss Contact Dermatitis Research Group. Contact Dermatitis 1994; 30: 276-9.
14. Moller H. Why thimerosal allergy? Int J Dermatol 1980; 19: 29.
15. th ed. Philadelphia: Lippincott Williams & Wilkins; 2001: 9-26.
16. Forstrom L, Hannuksela M, Kousa M, Lehmuskallio E. Merthiolate hypersensitivity and vaccination. Contact Dermatitis 1980; 6: 241-5.
17. Osawa J, Kitamura K, Ikezawa Z, Nakajima H. A probable role for vaccines containing thimerosal in thimerosal hypersensitivity. Contact Dermatitis 1991; 24: 178-82.
18. Wantke F, Hemmer W, Jarisch R, Gotz M. Patch test reactions in children, adults and the elderly. A comparative study in patients with suspected allergic contact dermatitis. Contact Dermatitis 1996; 34: 316-9.
19. Schafer T, Enders F, Przybilla B. Sensitization to thimerosal and previous vaccination. Contact Dermatitis 1995; 32: 114-6.
20. Wray D. Thiomersal sensitivity in health care workers. Br Dent J 1997; 183: 316.
21. Rees S, Gibson J, Forsyth A, Wray D. Thiomersal sensitivity in health care workers. Br Dent J 1997; 183: 395.
22. Handley J, Todd D, Burrows D. Mercury allergy in a contact dermatitis clinic in Northern Ireland. Contact Dermatitis 1993; 29: 258-61.
23. Brasch J, Geier J, Schnuch A. Differentiated contact allergy lists serve in quality improvement. Hautarzt 1998; 49: 184-91.
24. Rietschel RL, Adams RM. Reactions to thimerosal in hepatitis B vaccines. Dermatol Clin 1990; 8: 161-4.
25. Zenarola P, Gimma A, Lomuto M. Systemic contact dermatitis from thimerosal. Contact Dermatitis 1995; 32: 107-8.
26. Wong WK, Tan C, Ng SK, Goh CL. Thimerosal allergy and its relevance in Singapore. Contact Dermatitis 1992; 26: 195-6.
27. Aberer W. Vaccination despite thimerosal sensitivity. Contact Dermatitis 1991; 24: 6-10.
28. Cox NH, Forsyth A. Thiomersal allergy and vaccination reactions. Contact Dermatitis 1988; 18: 229-33.
29. van't Veen AJ. Vaccines without thiomersal: why so necessary, why so long coming? Drugs 2001; 61: 565-72.
30. Clements CJ, Ball LK, Ball R, Pratt RD. Thiomersal in vaccines: is removal warranted? Drug Saf 2001; 24: 567-74.